Cancer clinical trials are traditionally some of the most complex, and time-consuming trials for patients to participate in.  Join industry leaders who share opinions and perspectives on a traditionally “taboo” concept… oncology study participant stipends.  As the industry seeks to better identify, and better connect with cancer patients about the opportunities presented from participating in clinical trials…is it unreasonable to consider stipends for the time, effort, and risk of consenting to a trial?